X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (189) 189
Conference Proceeding (35) 35
Patent (23) 23
Publication (3) 3
Dissertation (2) 2
Book Chapter (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (90) 90
index medicus (75) 75
humans (61) 61
male (58) 58
female (55) 55
aged (54) 54
chemotherapy (53) 53
middle aged (52) 52
adult (44) 44
cancer (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
gastric cancer (26) 26
medicine & public health (26) 26
treatment outcome (26) 26
prognosis (25) 25
stomach neoplasms - pathology (24) 24
survival (22) 22
cisplatin (21) 21
colorectal cancer (21) 21
stomach neoplasms - drug therapy (21) 21
aged, 80 and over (20) 20
stomach cancer (20) 20
care and treatment (19) 19
metastasis (19) 19
retrospective studies (19) 19
fluorouracil (18) 18
neoplasm staging (18) 18
colorectal neoplasms - pathology (16) 16
surgical oncology (16) 16
cancer research (15) 15
survival rate (14) 14
trial (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
disease-free survival (13) 13
5-fluorouracil (12) 12
analysis (12) 12
irinotecan (12) 12
paclitaxel (12) 12
supportive care (12) 12
young adult (12) 12
camptothecin - analogs & derivatives (11) 11
colorectal neoplasms - drug therapy (11) 11
drug combinations (11) 11
patients (11) 11
bevacizumab (10) 10
carcinoma (10) 10
fluorouracil - administration & dosage (10) 10
gastroenterology & hepatology (10) 10
surgery (10) 10
antimitotic agents (9) 9
antineoplastic agents (9) 9
camptothecin - administration & dosage (9) 9
gastroenterology (9) 9
japan (9) 9
methotrexate (9) 9
oxonic acid - administration & dosage (9) 9
randomized phase-iii (9) 9
second-line chemotherapy (9) 9
tegafur - administration & dosage (9) 9
tumors (9) 9
adenocarcinoma - drug therapy (8) 8
antineoplastic agents - therapeutic use (8) 8
chemoradiotherapy (8) 8
esophageal cancer (8) 8
kaplan-meier estimate (8) 8
leucovorin (8) 8
medical prognosis (8) 8
oxaliplatin (8) 8
pathology (8) 8
peritoneal neoplasms - secondary (8) 8
radiotherapy (8) 8
research (8) 8
antimetabolites, antineoplastic - administration & dosage (7) 7
blasting (7) 7
cetuximab (7) 7
colorectal neoplasms - mortality (7) 7
heating (7) 7
lighting (7) 7
mechanical engineering (7) 7
open-label (7) 7
peritoneal neoplasms - drug therapy (7) 7
physics (7) 7
plus (7) 7
positive displacement machines for liquids (7) 7
pumps (7) 7
pumps for liquids or elastic fluids (7) 7
s-1 (7) 7
squamous cell carcinoma (7) 7
survival analysis (7) 7
therapy (7) 7
weapons (7) 7
1st-line therapy (6) 6
animals (6) 6
cancer patients (6) 6
cell biology (6) 6
cisplatin - administration & dosage (6) 6
follow-up studies (6) 6
infusions, intravenous (6) 6
liver neoplasms - drug therapy (6) 6
liver neoplasms - secondary (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2018, pp. 1 - 7
In the current era of targeted therapies, the benefits of resection of primary tumors in patients with unresectable stage IV colorectal cancer, specifically... 
Unresectable colorectal cancer | Palliative resection | Propensity score | Stage IV | Targeted therapy | Chemotherapy | Colorectal cancer | Gastrointestinal surgery
Journal Article
by Yamagami, Keitaro and Kurogi, Ryota and Kurogi, Ai and Nishimura, Kunihiro and Onozuka, Daisuke and Ren, Nice and Kada, Akiko and Nishimura, Ataru and Arimura, Koichi and Ido, Keisuke and Mizoguchi, Masahiro and Sakamoto, Tetsuya and Kayama, Takamasa and Suzuki, Michiyasu and Arai, Hajime and Hagihara, Akihito and Iihara, Koji and Masayoshi, Takigami and Kenji, Kamiyama and Kiyohiro, Houkin and Shougo, Nishi and Tetsuyuki, Yoshimoto and Sadao, Kaneko and Koji, Oka and Hiroshi, Ooyama and Kyousuke, Kamada and Kenichi, Makino and Naoki, Tokumitsu and Kazuhiro, Sako and Susumu, Suzuki and Nozomi, Suzuki and Naoto, Izumi and Kazumi, Nitta and Masahumi, Ootaki and Masanori, Isobe and Mikio, Nishiya and Takaaki, Yamazaki and Syouji, Mabuchi and Kuniaki, Ogasawara and Naohiko, Kubo and Yukihiko, Shimizu and Keiichi, Saito and Tatumi, Yamanome and Atsuo, Yoshino and Mitsuyuki, Fujitsuka and Masaaki, Takami and Hirotoshi, Ohtaka and Teruyuki, Hirano and Yosiaki, Shiokawa and Takaharu, Okada and Ichiro, Suzuki and Michihiro, Kohno and Jou, Haraoka and Yoshinori, Arai and Noriyoshi, Kawamura and Akira, Isoshima and Masaharu, Yasue and Mitsuhiko, Hokari and Takayoshi, Kobayashi and Kensuke, Kawai and Taketoshi, Maehara and Hajime, Arai and Makoto, Noguchi and Haruhiko, Hoshino and Hirofumi, Hiyama and Kensaku, Yoshida and Osamu, Utsugi and Yasuaki, Takeda and Kouichi, Tamaki and Hirohide, Karasudani and Takao, Urabe and Shiro, Kobayashi and Michio, Nakamura and Yorio, Koguchi and Junichi, Ono and Sumio, Suda and Hiromu, Hadeishi and Toshio, Fukutake and Kenji, Wakui and Hirokazu, Tanno and Naoki, Ishige and Takashi, Ohasi and Hideki, Sakai and Yasuaki, Nishimura and Takayuki, Watanabe and Takashi, Matsumoto and Naoki, Koketsu and Yuichi, Hirose and Manabu, Doyu and Toshinori, Hasegawa and Naoto, Kuwayama and Shinichi, Terao and Nobuhiko, Mizutani and Noriyuki, Suzaki and Satoshi, Okuda and Keizo, Yasui and Yukio, Seki and Yasuhiro, Hasegawa and Akira, Ikeda and Youtarou, Takeuchi and ... and J-ASPECT Study Collaborators
World Neurosurgery, ISSN 1878-8750, 2019
Background: The epidemiology of patients with traumatic brain injury (TBI) has changed dramatically over recent decades as a result of rapid advances in aging... 
Aging | Hospital mortality | Prognosis | Traumatic brain injury | Subdural hematoma | Index Medicus
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2017, Volume 20, Issue 4, pp. 655 - 662
Journal Article
Anticancer Research, ISSN 0250-7005, 07/2019, Volume 39, Issue 7, pp. 3931 - 3936
Background/Aim: Platinum plus 5-fluorouracil (FP) is a first-line regimen of palliative chemotherapy for recurrent or metastatic esophageal squamous cell... 
Esophageal carcinoma | Squamous cell carcinoma | Effectiveness | 5-Fluorouracil | Metastasis | Dosage | Disease control | Survival | Esophagus | Metastases | Refractory materials | Chemotherapy | Salvage | Platinum | Index Medicus
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 5/2019, Volume 26, Issue 5, pp. 1358 - 1365
When treated with molecular targeted agents, patients with unresectable colorectal cancer with right-sided tumors have poorer prognoses than those with... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | III COLON-CANCER | ONCOLOGY | RESECTION | SUBTYPES | OUTCOMES | SOCIETY | Chemotherapy | Prognosis | Gastrointestinal diseases | Analysis | Oncology, Experimental | Colorectal cancer | Research | Tumors | Cancer
Journal Article
Gastric Cancer, ISSN 1436-3291, 5/2018, Volume 21, Issue 3, pp. 439 - 445
Journal Article
Cancer Science, ISSN 1347-9032, 08/2014, Volume 105, Issue 8, pp. 1002 - 1007
c‐ MET is implicated in the pathogenesis and growth of a wide variety of human malignancies, including colorectal cancer ( CRC ). The aim of the present study... 
expression | hepatic metastasectomy | MET | Colorectal cancer | genetic mutational status | relapse‐free survival | Genetic mutational status | Hepatic metastasectomy | C-MET expression | Relapse-free survival | PRIMARY TUMORS | PIK3CA MUTATIONS | TYROSINE KINASE | KRAS STATUS | RECEPTOR | BRAF | relapse-free survival | BREAST-CANCER | CETUXIMAB | THERAPY | ONCOLOGY | CORRESPONDING METASTASES | c-MET expression | Immunohistochemistry | ras Proteins - genetics | Proto-Oncogene Proteins c-met - biosynthesis | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Hepatectomy | Young Adult | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colorectal Neoplasms - metabolism | Neoplasm Recurrence, Local - metabolism | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Proportional Hazards Models | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Class I Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins B-raf - genetics | Liver Neoplasms - metabolism | Neoplasm Recurrence, Local - genetics | Aged | Colorectal Neoplasms - pathology | Genetic research | Care and treatment | Genetic aspects | Surgery | Liver | Laboratories | Colorectal carcinoma | Metastasis | Family medical history | Kinases | Cancer therapies | Metastases | Proteins | Liver cancer | Ultrasonic imaging | Tomography | Growth factors | Antigens | Survival | Patients | Abdomen | Studies | Gene amplification | Medical prognosis | Protein expression | Mutation | Tumors | Index Medicus | Original
Journal Article
European Journal of Cancer, ISSN 0959-8049, 03/2018, Volume 91, pp. 86 - 91
Nanoparticle albumin-bound (nab)-paclitaxel was developed to improve paclitaxel solubility and does not need premedication to avoid infusion-related reactions... 
Second-line chemotherapy | Overall response rate | Ramucirumab | Advanced gastric cancer | Nab-paclitaxel | Paclitaxel | 2ND-LINE CHEMOTHERAPY | OPEN-LABEL | TRIAL | SUPPORTIVE CARE | ONCOLOGY | ALBUMIN-BOUND PACLITAXEL | IRINOTECAN | PLUS | Nanoparticles | Chemotherapy | Stomach cancer | Quality of life | Index Medicus
Journal Article
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 06/2019, Volume 37, Issue 3, pp. 573 - 578
Neuroendocrine tumors (NET) are rare tumors for which somatostatin analogs (SSA) are used not only for symptom control due to a functioning tumor, but also for... 
Octoreotide | Foregut NET | Neuroendocrine tumor | Hindgut NET | Lanreotide | Somatostatin analog | Complications and side effects | Dosage and administration | Effectiveness | Hindgut | Midgut | Liver | Medical treatment | Medical services | Disease control | Survival | Patients | Subgroups | Metastases | Analogs | Studies | Somatostatin | Foregut | Tumors | Neuroendocrine tumors
Journal Article
BMC CANCER, ISSN 1471-2407, 07/2019, Volume 19, Issue 1, pp. 755 - 755
BackgroundFor brain metastases from non-specific primary tumors, the most frequently used and validated clinical prognostic assessment tool is Karnofsky... 
SURVIVAL | STEREOTACTIC RADIOSURGERY | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | Colorectal cancer | VALIDATION | Brain metastases | RELIABILITY | Karnofsky performance status | RADIOTHERAPY | VALIDITY | ANALYSIS RPA | Complications and side effects | Prognosis | Metastasis | Brain tumors | Index Medicus
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2014, Volume 17, Issue 3, pp. 522 - 528
Journal Article